PHP
AUGX

Parkman Healthcare Partners’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Parkman Healthcare Partners’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-566,845
Closed -$499K – 106
2024
Q2 		$499K Sell
566,845
-499,264
-47% -$1.03M 0.07% 86
2024
Q1 		$4.36M Buy
1,066,109
+50,295
+5% +$225K 0.54% 62
2023
Q4 		$5.94M Buy
1,015,814
+639,732
+170% +$3.37M 0.84% 38
2023
Q3 		$1.94M Buy
+376,082
New +$1.76M 0.35% 76

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Parkman Healthcare Partners's AUGX Position: Q3 2024 in Review

Parkman Healthcare Partners sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 566,845 shares — an estimated $499K sold.

Parkman Healthcare Partners first reported a position in AUGX in Q3 2023 and held it in 4 quarters. The position peaked at $5.94M in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Parkman Healthcare Partners reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 566,845 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $499K.
  • Parkman Healthcare Partners first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
  • Parkman Healthcare Partners's Augmedix, Inc. Common Stock position peaked at $5.94M in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.